CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-24 | MOTT DAVID M Director | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
| 2020-01-24 | Florence Anthony A. Jr. 10% owner | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
| 2020-01-24 | Behbahani Ali Director | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
| 2020-01-24 | BASKETT FOREST 10% owner | Purchase | +7,500,000 | $0.67 | $5.0M | 19,500,000 |
| 2020-01-16 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +201,600 | 201,600 | ||
| 2020-01-16 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +135,600 | 135,600 | ||
| 2020-01-16 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +1,257,744 | 1,257,744 | ||
| 2020-01-16 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Grant or award · Option to purchase Ordinary Shares | +280,896 | 280,896 | ||
| 2020-01-16 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +1,257,744 | 1,257,744 | ||
| 2020-01-16 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +280,896 | 280,896 | ||
| 2020-01-16 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +1,257,744 | 1,257,744 | ||
| 2020-01-16 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +280,896 | 280,896 | ||
| 2020-01-16 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +2,515,536 | 2,515,536 | ||
| 2020-01-16 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +561,792 | 561,792 | ||
| 2020-01-14 | Norry Elliot Chief Medical Officer | Sale | −911 | $5.13 | $5K | 1,326 |
| 2020-01-14 | Bertrand William C JR Chief Operating Officer | Sale | −2,397 | $5.13 | $12K | 3,605 |
| 2020-01-14 | Lunger John Chief Patient Supply Officer | Sale | −1,144 | $5.13 | $6K | 1,681 |
| 2020-01-14 | Rawcliffe Adrian Chief Executive Officer | Sale | −3,236 | $5.13 | $17K | 3,166 |
| 2020-01-13 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Sale | −50,000 | $4.00 | $200K | 0 |
| 2020-01-13 | TAYTON-MARTIN HELEN KATRINA Chief Business Officer | Sale | −50,000 | $5.00 | $250K | 0 |
Page 14 of 23 · 454 trades